Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Research Inclusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01417533
What this trial is testing

A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases

Who this might be right for
GNE MyopathyGNE Related Diseases
National Human Genome Research Institute (NHGRI) 78
Early research (Phase 1)Ended earlyNCT05028114
What this trial is testing

Tricaprilin Liquid Formulation PK Study

Who this might be right for
Alzheimer Disease
Cerecin 71
Early research (Phase 1)Looking for participantsNCT06693362
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses

Who this might be right for
Severe Viral Pneumonia(Not Include COVID-19)
Ruijin Hospital 60
Not applicableLooking for participantsNCT06522256
What this trial is testing

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial

Who this might be right for
HPV InfectionAnal Cancer
ANRS, Emerging Infectious Diseases 100
Large-scale testing (Phase 3)Ended earlyNCT02951156
What this trial is testing

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pfizer 29
Not applicableStudy completedNCT01784679
What this trial is testing

GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body MyopathyGNE MyopathyNonaka Disease+2 more
Ultragenyx Pharmaceutical Inc 319
Not applicableLooking for participantsNCT06645236
What this trial is testing

DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
QIAGEN Gaithersburg, Inc 600
Not applicableStudy completedNCT00792129
What this trial is testing

MIS MiLIF Versus Open

Who this might be right for
Chronic Low Back PainLeg Pain
Zimmer Biomet 113
Not applicableStudy completedNCT06279910
What this trial is testing

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

Who this might be right for
SARS-CoV 2 Pneumonia
Complejo Hospitalario Universitario de Albacete 230
Not applicableNot Yet RecruitingNCT07535996
What this trial is testing

IBM Dietary Surveillance Study

Who this might be right for
Inclusion Body Myositis
Manchester Metropolitan University 47
Early research (Phase 1)Study completedNCT05408780
What this trial is testing

A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Who this might be right for
Alzheimer Disease
Cerecin 45
Early research (Phase 1)Study completedNCT04659031
What this trial is testing

ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)

Who this might be right for
Inclusion Body Myositis
Abcuro, Inc. 19
Large-scale testing (Phase 3)Study completedNCT02377921
What this trial is testing

Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body MyopathyDistal Myopathy With Rimmed VacuolesDistal Myopathy, Nonaka Type+1 more
Ultragenyx Pharmaceutical Inc 89
Testing effectiveness (Phase 2)Study completedNCT04669002
What this trial is testing

EP0057 in Combination With Olaparib in Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Ellipses Pharma 34
Not applicableStudy completedNCT00448877
What this trial is testing

Deployment of Functional Optical Brain Monitor [fNIR] in Clinical Anesthesia

Who this might be right for
Surgical Procedures, Operative
Drexel University College of Medicine 50
Testing effectiveness (Phase 2)WithdrawnNCT03710941
What this trial is testing

Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT01148810
What this trial is testing

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT03880734
What this trial is testing

This Study Include Asthma Chronic Obstructive Pulmonary Disease (COPD) Overlap Patients.Patients Were Vitamin D Deficient.Age Range 40-70 Years, Smokers.Patients Were Advised to Take Either Placebo or Vitamin D3.Lung Functions and Exercise Tolerance Were Assessed at Baseline and at 26th Weeks.

Who this might be right for
Asthma-COPD Overlap Syndrome
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 70
Not applicableStudy completedNCT05528718
What this trial is testing

SMILE Trial - Imaging Sub-Study

Who this might be right for
Major Depressive Disorder
Unity Health Toronto 11
Testing effectiveness (Phase 2)Study completedNCT02346461
What this trial is testing

An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy

Who this might be right for
GNE Myopathy
National Human Genome Research Institute (NHGRI) 12
Next Page